TrialThe Lancet. Respiratory medicine2023

Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.

Ahmet Z Uluer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.